Study on possible correlation between carcinogenic risk and genetic variation of hepatitis B and C viruses in Indonesia.

印度尼西亚乙型和丙型肝炎病毒致癌风险与遗传变异之间可能相关性的研究。

基本信息

  • 批准号:
    16406015
  • 负责人:
  • 金额:
    $ 6.78万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

1. Analysis of hepatitis B virus (HBV) : All of HBV isolates obtained in Surabaya, Indonesia, were classified into genotype B on the basis of partial S region sequences of the HBV genome while they were classified into genotype C on the basis of preC/C region sequences of the HBV genome. These results strongly suggest the possibility that these Indonesian HBV strains emerged through genetic recombination between genotypes B and C. There are 32 nucleotide residues (4.5% of the entire preC/C region sequence) that appear to be typical for genotype C, among which 7 residues (corresponding to 6 amino acid residues ; 2.8% of the entire preC/C peptides) are non-synonymous mutations. This recombinant type of HBV between genotypes B and C was isolated from all types of disease status, such asymptomatic carrier, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Interestingly, HBV isolates obtained from patients with liver cirrhosis and hepatocellular carcinoma had a tendency to po … More ssess quasi-species sequences with a unique sequence at the carboxy-terminus that are rarely found in asymptomatic carriers and patients with chronic hepatitis.2. Analysis of hepatitis C virus (HCV) : On the basis of secondary structure of the amino-terminal 120 residues of the NS3 protein, a majority of HCV isolates obtained in Surabaya, Indonesia, were classified into subgroup B1-1, which were shown to be closely associated with the occurrence of hepatocellular carcinoma in Japanese patients. Moreover, unique subgroups of HCV, which were rarely found in Japan, were frequently isolated in Indonesia. Although statistical significance was not achieved due probably to the small number of samples tested, it was interesting that HCV strains of the B1-1 subgroup prevail in Indonesia, where HCV-associated hepatocellular carcinoma is pretty common. We also observed that a considerable number of HCV isolates obtained from patients with hepatocellular carcinoma possessed four or more mutations in the interferon sensitivity-determining region (ISDR) of the NS5A protein. This result implies the possible benefit of interferon treatment for patients with HCV-associated hepatocellular carcinoma. Less
1. B型肝炎病毒(HBV)的分析:根据HBV基因组的部分S区序列将所有从印度尼西亚泗水获得的HBV分离株分类为基因型B,而根据HBV基因组的前C/C区序列将它们分类为基因型C。这些结果强烈提示这些印度尼西亚HBV毒株通过基因型B和C之间的遗传重组而出现的可能性。有32个核苷酸残基(整个preC/C区序列的4.5%),似乎是典型的基因型C,其中7个残基(对应于6个氨基酸残基;整个preC/C肽的2.8%)是非同义突变。这种介于基因型B和C之间的重组型HBV分离自所有类型的疾病状态,如无症状携带者、慢性肝炎、肝硬化和肝细胞癌。有趣的是,从肝硬化和肝细胞癌患者中获得的HBV分离株有感染的倾向, ...更多信息 SSSS准种序列在羧基端具有独特的序列,在无症状携带者和慢性肝炎患者中很少发现。丙型肝炎病毒(HCV)的分析:根据NS 3蛋白氨基末端120个残基的二级结构,将在印度尼西亚泗水获得的大多数HCV分离株分为B1-1亚组,该亚组显示与日本患者肝细胞癌的发生密切相关。此外,在日本很少发现的独特的HCV亚群在印度尼西亚经常被分离出来。尽管可能由于检测的样本数量较少而未达到统计学显著性,但有趣的是,HCV B1-1亚群毒株在印度尼西亚流行,HCV相关肝细胞癌在印度尼西亚非常常见。我们还观察到,相当数量的HCV分离株获得的肝细胞癌患者具有四个或更多的突变的干扰素敏感性决定区(ISDR)的NS 5A蛋白。这一结果意味着干扰素治疗HCV相关肝细胞癌患者的可能益处。少

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
B型肝炎ワクチン
乙型肝炎疫苗
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Cleavage of the hepatitis C virus NS5A protein by caspase-3 in the interferon sensitivity-determining region in a sequence-dependent manner.
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Hidajat;M. Nagano‐Fujii;Lin Deng;H. Hotta
  • 通讯作者:
    R. Hidajat;M. Nagano‐Fujii;Lin Deng;H. Hotta
Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference.
  • DOI:
    10.1016/j.antiviral.2006.01.009
  • 发表时间:
    2006-07
  • 期刊:
  • 影响因子:
    7.6
  • 作者:
    Otaki M;Sada K;Kadoya H;Nagano-Fujii M;Hotta H
  • 通讯作者:
    Hotta H
NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner
  • DOI:
    10.1099/vir.0.81735-0
  • 发表时间:
    2006-06-01
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Deng, Lin;Nagano-Fujii, Motoko;Hotta, Hak
  • 通讯作者:
    Hotta, Hak
Suppression of hepatitis C virus replicon by RNA interference directed against the N53 and NS5B regions of the viral genome.
通过针对病毒基因组 N53 和 NS5B 区域的 RNA 干扰抑制丙型肝炎病毒复制子。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takigawa Yuki
  • 通讯作者:
    Takigawa Yuki
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOTTA Hak其他文献

HOTTA Hak的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOTTA Hak', 18)}}的其他基金

Study on molecular mechanisms of glucose metabolic disorders mediated by hepatitis C virus
丙型肝炎病毒介导的糖代谢紊乱的分子机制研究
  • 批准号:
    24590976
  • 财政年份:
    2012
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Viral factors that determine viremia titers of hepatitis C virus in Indonesia
决定印度尼西亚丙型肝炎病毒病毒血症滴度的病毒因素
  • 批准号:
    13576015
  • 财政年份:
    2001
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
  • 批准号:
    11691209
  • 财政年份:
    1999
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
  • 批准号:
    10041196
  • 财政年份:
    1998
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Inhibition of apoptosis by the NS3 protein of hepatitis C virus and its interaction with the p53 tumor suppressor protein.
丙型肝炎病毒 NS3 蛋白对细胞凋亡的抑制及其与 p53 肿瘤抑制蛋白的相互作用。
  • 批准号:
    09670317
  • 财政年份:
    1997
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on hepatitis C virus new genotypes in Southeast Asia
东南亚丙型肝炎病毒新基因型研究
  • 批准号:
    08041176
  • 财政年份:
    1996
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
  • 批准号:
    487828
  • 财政年份:
    2023
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
  • 批准号:
    478700
  • 财政年份:
    2023
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
  • 批准号:
    469805
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10449670
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
  • 批准号:
    10709130
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
  • 批准号:
    460792
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
    Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
  • 批准号:
    10683045
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10620846
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
  • 批准号:
    10597168
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
The effect of opioids, stimulants, and the simultaneous use of both on the hepatitis C virus (HCV) cascade of care in rural communities in the United States
阿片类药物、兴奋剂以及同时使用两者对美国农村社区丙型肝炎病毒 (HCV) 级联护理的影响
  • 批准号:
    10459753
  • 财政年份:
    2022
  • 资助金额:
    $ 6.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了